Brief: S2Medical Validates European Patent For AMP Technology In 18 Countries

S2Medical AB (publ)

02/02/2026 07:34

Feb 2 (Reuters) - S2Medical AB (publ) S2ME.ST:

SAID ON FRIDAY EUROPEAN PATENT EP 4056195 HAS NOW BEEN VALIDATED AND ENTERED INTO FORCE IN 18 EUROPEAN COUNTRIES

VALIDATION GIVES S2MEDICAL LONG-TERM PATENT PROTECTION UNTIL FEBRUARY 20, 2039

IN TOTAL, THE PATENT PROTECTION COVERS AUSTRIA, BELGIUM, BULGARIA, GERMANY, DENMARK, ESTONIA, FINLAND, FRANCE, ITALY, LITHUANIA, LUXEMBOURG, LATVIA, MALTA, THE NETHERLANDS, PORTUGAL, SWEDEN, SLOVENIA AND ROMANIA

 Source text for Workspace: nMFN3wkCm3
 Further company coverage: S2ME.ST

 (Gdansk Newsroom)

 ((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))